Richard S. Finn

Also affiliated with The Royal Free Hospital, University College London

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma”.

Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma

New England Journal of Medicine(2020)10.1056/nejmoa1915745

N/A

1.3DataRank · unranked

7029 citations

Shukui Qin, Masafumi Ikeda, Peter R. Galle, Michel Ducreux, Tae-You Kim +19 more

Purification of HCC-specific extracellular vesicles on nanosubstrates for early HCC detection by digital scoring

Nature Communications(2020)10.1038/s41467-020-18311-0

N/A

0.817DataRank · unranked

231 citations

Yi‐Te Lee, Ryan Y. Zhang, Rueihung Kao, Pai‐Chi Teng, Yingying Yang +30 more

HCC EV ECG score: An extracellular vesicle‐based protein assay for detection of early‐stage hepatocellular carcinoma

Hepatology(2022)10.1002/hep.32692

N/A

0.678DataRank · unranked

91 citations

Ceng Zhang, Yi‐Te Lee, Benjamin V. Tran, Jing Wang, Hyo Yong Kim +49 more

Interventional Oncology Meets Immuno-oncology: Combination Therapies for Hepatocellular Carcinoma

Radiology(2024)10.1148/radiol.232875

N/A

0.618DataRank · unranked

19 citations

Riad Salem, Richard S. Finn, Tim F. Greten, S. Nahum Goldberg, Julius Chapiro +1 more

Phase II Study of Palbociclib (PD-0332991) in CCND1 , 2 , or 3 Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1B

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-2150

N/A

0.457DataRank · unranked

20 citations

Fangxin Hong, Richard S. Finn, Angela DeMichele, Edith P. Mitchell, James A. Zwiebel +18 more

Covalent Chemistry‐Mediated Multimarker Purification of Circulating Tumor Cells Enables Noninvasive Detection of Molecular Signatures of Hepatocellular Carcinoma

Advanced Materials Technologies(2021)10.1002/admt.202001056

N/A

0.330DataRank · unranked

8 citations

Yi‐Te Lee, Minhyung Kim, Jasmine J. Wang, Ceng Zhang, Pai‐Chi Teng +21 more

Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma

Nature Reviews Clinical Oncology(2024)10.1038/s41571-024-00868-0

N/A

0DataRank · unranked

346 citations

Roser Pinyol, Mark Yarchoan, Amit G. Singal, Thomas U. Marron, Myron E. Schwartz +4 more

Critical Appraisal of Guideline Recommendations on Systemic Therapies for Advanced Hepatocellular Carcinoma

JAMA Oncology(2023)10.1001/jamaoncol.2023.2677

N/A

0DataRank · unranked

151 citations

Virginia Corbett, Mark Yarchoan, Richard S. Finn, Josep M. Llovet, Sarah Cappuyns

Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus Conference

Hepatology(2020)10.1002/hep.31327

N/A

0DataRank · unranked

414 citations

Augusto Villanueva, Jorge A. Marrero, Myron E. Schwartz, Tim Meyer, Peter R. Galle +9 more

Somatic copy number profiling from hepatocellular carcinoma circulating tumor cells

npj Precision Oncology(2020)10.1038/s41698-020-0123-0

N/A

0DataRank · unranked

19 citations

Shuang Hou, Lian Liu, Paul Winograd, Benjamin J. DiPardo, Sean X. Liu +14 more